Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
| Income Statement [Abstract] | ||||
| Revenues | $ 13,548 | $ 12,596 | $ 31,780 | $ 45,593 |
| Costs and expenses: | ||||
| Cost of sales | 8,498 | 7,281 | 19,383 | 28,650 |
| Selling, general and administrative | 4,968 | 5,789 | 16,045 | 19,711 |
| Restructuring charge | 0 | 1,108 | 119 | 1,425 |
| Research and development | 216 | 672 | 780 | 1,438 |
| Building impairment | 0 | 0 | 2,965 | 0 |
| Costs and expenses: | 13,682 | 14,850 | 39,292 | 51,224 |
| Operating loss | (134) | (2,254) | (7,512) | (5,631) |
| Interest income | 2 | 5 | 8 | 21 |
| Other expense | (41) | (254) | (45) | (738) |
| Loss from continuing operations before income taxes | (173) | (2,503) | (7,549) | (6,348) |
| Income tax benefit (expense) | (5) | 114 | 10 | 208 |
| Net loss from continuing operations | (178) | (2,389) | (7,539) | (6,140) |
| Loss from discontinued operations (net of income tax benefit of $0 in 2017 and 2016) | (239) | (630) | (2,238) | (2,144) |
| Net loss | $ (417) | $ (3,019) | $ (9,777) | $ (8,284) |
| Basic | ||||
| Continuing operations (in dollars per share) | $ (0.01) | $ (0.10) | $ (0.32) | $ (0.26) |
| Discontinued operations (in dollars per share) | (0.01) | (0.03) | (0.09) | (0.09) |
| Basic net loss per common share (in dollars per share) | (0.02) | (0.13) | (0.41) | (0.35) |
| Diluted | ||||
| Continuing operations (in dollars per share) | (0.01) | (0.10) | (0.32) | (0.26) |
| Discontinued operations (in dollars per share) | (0.01) | (0.03) | (0.09) | (0.09) |
| Diluted net loss per common share (in dollars per share) | $ (0.02) | $ (0.13) | $ (0.41) | $ (0.35) |
| Weighted-average number of common shares outstanding: | ||||
| Basic (in shares) | 24,133,000 | 23,446,000 | 23,784,000 | 23,337,000 |
| Diluted (in shares) | 24,133,000 | 23,446,000 | 23,784,000 | 23,337,000 |